Mylan Asi Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MYLAN ASI
MYLAN ASI has four approved drugs.
Summary for Mylan Asi
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 4 |
Drugs and US Patents for Mylan Asi
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Asi | GRANISETRON HYDROCHLORIDE | granisetron hydrochloride | INJECTABLE;INJECTION | 091136-001 | Apr 9, 2010 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mylan Asi | GRANISETRON HYDROCHLORIDE | granisetron hydrochloride | INJECTABLE;INJECTION | 091137-002 | Apr 9, 2010 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mylan Asi | GRANISETRON HYDROCHLORIDE | granisetron hydrochloride | INJECTABLE;INJECTION | 091136-002 | Apr 9, 2010 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mylan Asi | ADENOSINE | adenosine | SOLUTION;INTRAVENOUS | 090212-002 | Mar 28, 2014 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
